Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ETHBiShares Staked Ethereum Trust ETF

Nasdaq · CIK 0002099103
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6221 Commodity Contracts Brokers & Dealers
FY end1231
XBRL facts65

Identity from submissions API

NameiShares Staked Ethereum Trust ETF
CIK0002099103
TickersETHB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6221 Commodity Contracts Brokers & Dealers
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone415-670-6416
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)0
Insider transactions (owner)0

Former names

  • None listed.
Business address
C/O ISHARES DELAWARE TRUST SPONSOR LLC
400 HOWARD STREET
SAN FRANCISCO
CA
94105
CA
Mailing address
C/O ISHARES DELAWARE TRUST SPONSOR LLC
400 HOWARD STREET
SAN FRANCISCO
CA
94105
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

25 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 8-K FORM 8-K 5.02 0001437749-26-036916 001-43185 261553448 34 164765 1 1
2026-11-06 IRANNOTICE FORM IRANNOTICE 0001437749-26-035549 001-43185 261531680 34 26003
2026-11-06 10-Q FORM 10-Q 0001437749-26-035531 001-43185 261531615 34 3037294 1 1
2026-10-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000886 005-95602 261439691 34 10680
2026-08-11 10-Q FORM 10-Q 0001437749-26-027003 001-43185 261263093 34 2987264 1 1
2026-07-31 424B3 FORM 424B3 0001437749-26-025220 333-291992 261228112 33 6729
2026-07-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000733 005-95602 261182483 34 10682
2026-06-05 8-K FORM 8-K 8.01 0001437749-26-019762 001-43185 261070257 34 170880 1 1
2026-05-07 IRANNOTICE FORM IRANNOTICE 0001437749-26-015549 001-43185 26952797 34 27155
2026-05-07 10-Q FORM 10-Q 0001437749-26-015530 001-43185 26952715 34 2391660 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000517 005-95602 26947331 34 10690
2026-04-15 424B3 FORM 424B3 0001437749-26-012417 333-291992 26864561 33 7494
2026-04-15 POS EX FORM POS EX 0001437749-26-012416 333-291992 26864550 33 165524
2026-04-15 8-K FORM 8-K 1.01,9.01 0001437749-26-012415 001-43185 26864543 34 306853 1 1
2026-04-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002052113-26-000370 005-95602 26844327 34 10648
2026-03-31 8-K FORM 8-K 5.02 0001437749-26-010474 001-43185 26816576 34 170328 1 1
2026-03-26 FWP FORM FWP 0001437749-26-009838 333-291992 26794098 34 743801
2026-03-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000788 333-291992 26745509 33 1810
2026-03-11 424B3 FORM 424B3 0001437749-26-007771 333-291992 26743748 33 1679654
2026-03-11 CERT ETHB_8-A_Cert_2099103.pdf 0001354457-26-000242 001-43185 26743071 34 130403
2026-03-09 8-A12B FORM 8-A12B 0001437749-26-007336 001-43185 26734616 34 25112
2026-03-06 S-1/A FORM S-1/A 0001437749-26-007228 333-291992 26732095 33 196211
2026-03-02 S-1/A FORM S-1/A 0001437749-26-006395 333-291992 26708817 33 1926409
2026-02-17 S-1/A FORM S-1/A 0001437749-26-004276 333-291992 26638025 33 4293846
2025-12-08 S-1 FORM S-1 0001437749-25-037057 333-291992 251554248 33 1857409 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (65 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 32.52M 2026-10-31 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap AccountsPayableFairValueDisclosure Accounts Payable, Fair Value Disclosure USD 104,085 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 2,531 2026-06-30 2026 Q2 10-Q 2026-08-11 0001437749-26-027003
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 2,317 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 2,317 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2,317 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetCost CryptoAssetCost USD 974.02M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetFairValue CryptoAssetFairValue USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetFairValueRestricted CryptoAssetFairValueRestricted USD 321.87M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015530
us-gaap CryptoAssetNumberOfRestrictedUnits CryptoAssetNumberOfRestrictedUnits pure 153,136 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015530
us-gaap CryptoAssetNumberOfUnits CryptoAssetNumberOfUnits pure 441,284 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 1.07B 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetRealizedGainLossOperating CryptoAssetRealizedGainLossOperating USD -12.00M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap CryptoAssetUnrealizedGainLossOperating CryptoAssetUnrealizedGainLossOperating USD 214.74M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 11.56 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap FairValueNetAssetLiability Fair Value, Net Asset (Liability) USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 202.75M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap GainLossOnSaleOfTrustAssetsToPayExpenses Gain (Loss) on Sale of Trust Assets to Pay Expenses USD -20,132 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap GrossInvestmentIncomeOperating Gross Investment Income, Operating USD 4.26M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 104,085 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 2,531 2026-01-14 2026-06-30 2026 Q2 10-Q 2026-08-11 0001437749-26-027003
us-gaap InvestmentCompanyDistributionOrdinaryIncome InvestmentCompanyDistributionOrdinaryIncome USD 2.62M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyDistributionToShareholdersPerShare Investment Company, Distribution to Shareholders, Per Share USD/shares 0.12 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyExpenseRatioAfterIncentiveAllocation Investment Company, Expense Ratio after Incentive Allocation pure 0.002 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyExpenseRatioBeforeIncentiveAllocation Investment Company, Expense Ratio before Incentive Allocation pure 0.003 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyGainLossOnInKindRedemption Investment Company, Gain (Loss) on in-kind Redemption USD -3.26M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyGainLossOnInvestmentPerShare Investment Company, Gain (Loss) on Investment, Per Share USD/shares 9.6 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare Investment Company, Investment Income (Loss) from Operations, Per Share USD/shares 9.8 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyInvestmentIncomeLossPerShare Investment Company, Investment Income (Loss), Per Share USD/shares 0.2 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyInvestmentIncomeLossRatio Investment Company, Investment Income (Loss) Ratio pure 0.01 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyTotalReturn Investment Company, Total Return pure 0.306 2026-04-22 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentCompanyTotalReturnAfterIncentiveFees Investment Company, Total Return after Incentive Fees pure 0.394 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentIncomeOperatingAfterExpenseAndTax InvestmentIncomeOperatingAfterExpenseAndTax USD 2.65M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 974.02M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentOwnedAtFairValue Investment Owned, at Fair Value USD 1.19B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap InvestmentOwnedPercentOfNetAssets Investment Owned, Percent of Net Assets pure 1 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 104,085 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap ManagementAndServiceFeesBaseRate ManagementAndServiceFeesBaseRate pure 0.003 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NetAssetValuePerShare Net Asset Value Per Share USD/shares 34.68 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 795.18M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -795.18M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 206.32M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NetInvestmentIncome Net Investment Income USD 3.57M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilities Non Investment Assets Less Non Investment Liabilities USD 101,768 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets Non Investment Assets Less Non Investment Liabilities, Percent of Net Assets pure 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap OperatingExpenses Operating Expenses USD 687,498 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -30,415 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001437749-26-015530
us-gaap PayableCommonStockRedeemed PayableCommonStockRedeemed USD 32.54M 2026-06-30 2026 Q2 10-Q 2026-08-11 0001437749-26-027003
us-gaap PaymentsOfDividends Payments of Dividends USD 2.97M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap ProceedsFromDispositionOfInvestmentOperatingActivity ProceedsFromDispositionOfInvestmentOperatingActivity USD 39.40M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 834.28M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -12.00M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap ReceivableInvestmentSale ReceivableInvestmentSale USD 2,106 2026-06-30 2026 Q2 10-Q 2026-08-11 0001437749-26-027003
us-gaap SponsorFees Sponsor Fees USD 1.13M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap StockIssued1 Stock Issued USD 233.84M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 37.72M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap StockIssuedDuringPeriodSharesPeriodIncreaseDecrease Stock Issued During Period, Shares, Period Increase (Decrease) shares 34.28M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquityIssuePeriodIncreaseOrDecrease Temporary Equity, Carrying Amount, Period Increase (Decrease) USD 364.81M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 34.68 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 34.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 34.28M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 388.94M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 214.74M 2026-01-15 2026-09-30 2026 Q3 10-Q 2026-11-06 0001437749-26-035531

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →